Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
IAC members
The IAC from left; Dr Ivor Zwane, Reneë Beck, Gus Silber, Luhlumelo Toyana, Dr Adri van der Merwe, Nick Efstathiou, Avela Ntsongelwa, Prof Colin Chasi, HOD Communication Department, Alzane Narrain, Nomvo Bam and Dr Gustav Puth.

Building ties with industry experts provides greater prospects for bursaries, prizes for top students, as well as informal internships. This is why the Department of Communication Science at the University of the Free State (UFS) took the bold and commendable step of soliciting the expertise of an Industry Advisory Council (IAC).

“As a department we believe it is important to stay in touch with the industry to ensure that we, and the work we do, stays relevant in order to increase the chances of making our students preferred candidates in the workplace,” said Dr Adri van der Merwe, lecturer at the department.

The advisory panel consisted of Reneë Beck, founder and CEO of Pink Lemon; Nick Efstathiou, newly appointed CEO of Central Media Group; DDr Ivor Zwane, chairman of the board for Small to Medium Enterprise Development; education journalist Gus Silber; journalist Alzane Narrain; Dr Gustav Puth, Academic Director of Post-Graduate Executive Education at Monash South Africa; photographer Luhlumelo Toyana; Avela Ntsongelwa,master's student and Nomvo Bam.

The initiative also created a platform for the students to engage with IAC members. The Department hosted the IAC on 6 March 2019 on the UFS Bloemfontein Campus.

Advice to assist in improving curriculum

“The IAC members’ feedback will influence our curriculum, both in the short term when we begin to shift emphasis on certain matters, as well as in the longer term when we replace or expand on specific modules,” Van der Merwe said.

The advice given by IAC members will be taken very seriously. “We have captured all their input on video, and will now, in preparation for our strategic planning session later this year, analyse and prioritise the actions we need to implement their proposals.” she said. The students are also represented on the IAC in order to hear and take into consideration what the students have to say about how the curriculum can be improved to prepare them more effectively for the workplace. 

The department plan on hosting the IAC yearly.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept